Hao Tian International Construction Investment (HKG:1341) subsidiary Glory Century signed a three-year licensing agreement with Aceso Life Science (HKG:0474) subsidiary Hao Tian Management (Hong Kong) for the use of office rooms in Wanchai, Hong Kong.
Under the agreement, Hao Tian will pay a monthly license fee to Glory Century of about HK$229,000 for the first year, HK$234,000 for the second year, and HK$239,000 for the third year, according to a Monday filing with the Hong Kong Exchange.
Shares closed 6% lower during Tuesday's trading.
Price (HKD): $0.47, Change: $-0.030, Percent Change: -6.00%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments